首页> European journal of nuclear medicine and molecular imaging> Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

导出 OA

翻译打印收藏纠错

第一作者： Emilio Francesco,Giunta

第一单位： Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. emiliofrancescogiunta@gmail.com.

作者： Emilio Francesco,Giunta ^[1] ; Paola,Caroli ^[2] ; Emanuela,Scarpi ^[3] ; Amelia,Altavilla ^[4] ; Virginia,Rossetti ^[2] ; Irene,Marini ^[2] ; Monica,Celli ^[2] ; Chiara,Casadei ^[4] ; Cristian,Lolli ^[4] ; Giuseppe,Schepisi ^[4] ; Sara,Bleve ^[4] ; Nicole,Brighi ^[4] ; Maria Concetta,Cursano ^[4] ; Giovanni,Paganelli ^[2] ; Federica,Matteucci ^[2] ; Ugo,De Giorgi ^[4]

作者单位： Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. emiliofrancescogiunta@gmail.com. ^[1] Department of Nuclear Medicine, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. ^[2] Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. ^[3] Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. ^[4]

关键词 Enzalutamide Monitoring response.PSMA PET Prostate cancer